Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
National Institute of Mental Health (NIMH) |
---|---|
Information provided by: | National Institute of Mental Health (NIMH) |
ClinicalTrials.gov Identifier: | NCT00149773 |
This study will assess the effectiveness of cognitive therapy in reducing the incidence of suicide ideation and behavior in older men in a primary care setting.
Condition | Intervention | Phase |
---|---|---|
Suicide, Attempted |
Behavioral: Cognitive Therapy |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Cognitive Therapy for Suicidal Older Men in Primary Care Settings |
Estimated Enrollment: | 48 |
Study Start Date: | May 2005 |
Older adult males have the highest suicide rate of any age group in the U.S. Over 70 percent of older suicide victims have been to their primary care physician within a month of their death, many with a depressive illness that was not detected. However, most research concerning treatments for suicide ideation and behavior has focused on adolescents and young adults. Very few treatments have been developed to reduce suicide ideation and behavior in men aged 60 and above. This study will assess the effectiveness of specialized cognitive therapy versus typical treatment in treating older men with suicide ideation.
Participants in this two-year, single-blind study will be randomly assigned to receive either cognitive therapy combined with enriched care or enriched care alone. Participants will be identified in primary care settings as having experienced suicide ideation in the past month. Cognitive therapy will be provided by Ph.D.-level therapists and will be geared specifically toward older men with suicidal tendencies. The enriched care condition will consist of the usual care that individuals receive for suicide prevention, plus assessment and referral services provided by independent evaluators and study case managers. All participants will be assessed pre-treatment to attain baseline measures of suicide ideation, hopelessness, and depression. Study visits will occur at baseline and Months 1, 3, 6, 12, 18, and 24 to assess suicide ideation. Self-report and clinician-administered measures will be used to assess participants' progress.
Ages Eligible for Study: | 60 Years and older |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Gregory K. Brown, PhD | 215-898-4104 | gregbrow@mail.med.upenn.edu |
United States, Pennsylvania | |
Psychopathology Research Unit - University of Pennsylvania | Recruiting |
Philadelphia, Pennsylvania, United States, 19104 | |
Contact: Gregory K Brown, PhD 215-898-4104 gregbrow@mail.med.upenn.edu | |
Contact: Barbara Marinelli 215-898-4102 marinell@mail.med.upenn.edu | |
Principal Investigator: Gregory K Brown, PhD | |
Principal Investigator: Aaron T Beck, MD |
Principal Investigator: | Aaron T. Beck, MD | University of Pennsylvania |
Principal Investigator: | Gregory K. Brown, PhD | University of Pennsylvania |
Study ID Numbers: | P20 MH71905-01, 802223, DSIR 83-ATP |
Study First Received: | September 6, 2005 |
Last Updated: | January 29, 2008 |
ClinicalTrials.gov Identifier: | NCT00149773 History of Changes |
Health Authority: | United States: Federal Government |
Cognitive therapy Suicide Older men Death ideation Primary care |
Death Suicide, Attempted Suicide Behavioral Symptoms Self-Injurious Behavior |
Suicide, Attempted Suicide Behavioral Symptoms Self-Injurious Behavior |